Latest filing published 15 Jan 2026 for Celularity Inc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Peter Diamandis is a declared insider at 3 companies (board member); the most frequent names are Celularity Inc, Vaxxinity, Inc. and DPCM Capital, Inc. In total, 18 filings cover trades dated from 15 November 2021 to 12 January 2026.
On the market, this insider has only sold: 1 sale, €2,848 in total. The rest of the record consists of 10 share grants and 3 option exercises.
The record was last updated on 15 January 2026 with a share grant in Celularity Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations